Replies to post #192918 on Biotech Values

[Bickema]

EXAS - do you like this as LT investment?

[DewDiligence]

EXAS’ 2Q15 results are in-line with guidance given on 6/25/15 Investor Day (#msg-114911581):

http://finance.yahoo.com/news/exact-sciences-highlights-cologuard-positive-090200489.html

Exact Sciences today announced its business and financial results for the second quarter of 2015, and showed continued strong performance with more than 21,000 completed Cologuard tests for the quarter, up more than 90 percent from the first quarter, which resulted in $8.1 million in revenue. Additionally, the cumulative number of ordering physicians grew to 14,700 during the quarter, a 77 percent increase.